InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+33.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Goyal Arjun, 董事. Director active across 1 company, notably Centessa Pharmaceuticals plc. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €492k. History available since 15 May 2025. The latest transaction was filed on 15 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Goyal Arjun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
462,585 股Ordinary SharesSEC:0001470831-26-000613:0
44,939 股@ US$12.2441100.0% 占其流量Ordinary SharesSEC:0001847903-25-000074:0
标准退出：2025年8月13日 (T+90)
3,095,909 股Ordinary SharesSEC:0000899243-21-022066:0
3 条申报中的 3 条
About Goyal Arjun
Arjun Goyal is a Director at Centessa Pharmaceuticals plc. In this role, he brings his expertise in corporate governance and strategy. His experience in the pharmaceutical sector allows him to effectively contribute to strategic decisions and the direction of Centessa Pharmaceuticals, ensuring its development and compliance.
